Increased incidence of infection in verapamil-treated kidney transplant recipients

Transplantation Proceedings

Volumn 32, Issue 3, 2000, Pages 551-553

  Nanni, G ^a,b   Panocchia, N ^a   Tacchino, R ^a   Foco, M ^a   Piccioni, E ^a   Castagneto, M ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; LYMPHOBLAST ANTIBODY; MITOGENIC AGENT; VERAPAMIL;

ACUTE KIDNEY TUBULE NECROSIS; CONFERENCE PAPER; CYTOLYSIS; GRAFT SURVIVAL; HUMAN; HYPERTENSION; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION RISK; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; NEPHROTOXICITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STATISTICAL ANALYSIS;

ANTILYMPHOCYTE SERUM; CALCIUM CHANNEL BLOCKERS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFECTION; KIDNEY TRANSPLANTATION; VERAPAMIL;

EID: 0034059207     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)00886-1     Document Type: Conference Paper

References (10)

1. Curtis JJ, Luke RG, Jones P, et al: Am J Med 85:134, 1988
2. Wagner K, Neumayer HH: Transplant Proc 19:1353, 1987
3. Dawidson I, Rooth P, Fry WR, et al: Transplantation 48:575, 1989
4. Weir MR: Am J Med 90 (Suppl 5A):32, 1991
5. Dawidson I, Rooth P: Am J Med 90 (Suppl 5A):37, 1991
6. Weir MR, Peppier R, Gomolka D, et al: Transplantation 51:851, 1991
7. Yamaguchi M, Suwa H, Miyasaka M, et al: Transplantation 63:759, 1997
8. Citterio F, Serino F, Pozzetto U, et al: Transplant Proc 28:2174, 1996
9. Mirza DF, Gunson BK, Soonawalla Z, et al: Lancet 349:701, 1997
10. Senel FM, Yildirim S, Karakayali, et al: Transplant Int 10:357, 1997